(Q40707428)

22 September 2017

title

Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line (English)

1 reference

22 September 2017

1 reference

1 reference

Yuzo Kodama

1

1 reference

22 September 2017

Robert C Baxter

series ordinal

2

1 reference

22 September 2017

Janet L Martin

series ordinal

3

1 reference

22 September 2017

language of work or name

1 reference

1 September 2002

1 reference

American Journal of Respiratory Cell and Molecular Biology

22 September 2017

published in

1 reference

22 September 2017

volume

27

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

336-344

1 reference

Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Insulin-like growth factor expression in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Insulin-like growth factor physiology and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Insulin-like growth factor-I has a biphasic effect on colon carcinoma cells through transient inactivation of forkhead1, initially mitogenic, then mediating growth arrest and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Regulation of protein kinase cascades by protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Alterations of the PPP2R1B gene in human lung and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

Ten years of protein kinase B signalling: a hard Akt to follow

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0021OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2002-0021OC

1 reference

22 September 2017

1 reference